CymaBay Therapeutics Inc (DELISTED) (CBAY:DL)
32.48
0.00 (0.00%)
USD |
NASDAQ |
Mar 25, 16:00
CymaBay Therapeutics Cash from Operations (TTM): -72.53M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -72.53M |
September 30, 2023 | -63.91M |
June 30, 2023 | -55.28M |
March 31, 2023 | -52.29M |
December 31, 2022 | -84.08M |
September 30, 2022 | -79.57M |
June 30, 2022 | -77.46M |
March 31, 2022 | -74.23M |
December 31, 2021 | -69.43M |
September 30, 2021 | -70.00M |
June 30, 2021 | -62.04M |
March 31, 2021 | -50.58M |
December 31, 2020 | -44.72M |
September 30, 2020 | -58.04M |
June 30, 2020 | -73.72M |
March 31, 2020 | -90.22M |
December 31, 2019 | -97.91M |
September 30, 2019 | -89.37M |
June 30, 2019 | -82.32M |
March 31, 2019 | -70.89M |
December 31, 2018 | -54.94M |
Date | Value |
---|---|
September 30, 2018 | -41.41M |
June 30, 2018 | -30.80M |
March 31, 2018 | -23.87M |
December 31, 2017 | -19.63M |
September 30, 2017 | -18.96M |
June 30, 2017 | -19.24M |
March 31, 2017 | -19.42M |
December 31, 2016 | -23.35M |
September 30, 2016 | -23.15M |
June 30, 2016 | -24.07M |
March 31, 2016 | -23.30M |
December 31, 2015 | -23.32M |
September 30, 2015 | -25.60M |
June 30, 2015 | -22.83M |
March 31, 2015 | -22.26M |
December 31, 2014 | -21.11M |
September 30, 2014 | -17.18M |
June 30, 2014 | -13.89M |
March 31, 2014 | -11.31M |
December 31, 2013 | -8.458M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-97.91M
Minimum
Dec 2019
-44.72M
Maximum
Dec 2020
-70.93M
Average
-72.53M
Median
Dec 2023
Cash from Operations (TTM) Benchmarks
Gilead Sciences Inc | 8.481B |
Assure Holdings Corp | -5.044M |
Societal CDMO Inc (DELISTED) | -1.005M |
AN2 Therapeutics Inc | -53.29M |
Madrigal Pharmaceuticals Inc | -324.23M |